This release has been authorised by the directors of Immuron Limited. Steven Lydeamore Chief Executive Officer ...

Jennifer B. Brooke Valerin, Jacob Thomas, J. Eva E. Selfridge, Madison Conces, Devalingam Mahalingam, Michael Cecchini, Elena G. Chiorean, Oana Danciu, Kyechin Chen, Ana Paula G. Cugnetti, Judith ...

Separately, BioStem remains actively engaged in its Form 10 filing process and will provide additional updates on its planned Nasdaq uplisting during its second quarter 2025 earnings call.

Castle earns recognition as a national Healthcare Industry Top Workplace, an Arizona Top Workplace and receives five Top Workplaces Culture Excellence awards ...

When paired with oral legal peptides focused on recovery and muscle support, this stack becomes a dual-threat system: fat burning from one side, lean muscle retention from the other. Athletes report ...

Top Workplaces Industry awards celebrate organizations that have built people-first workplace cultures within their sector. The award marks them as an employer of choice for those seeking employment ...

ATLANTA, July 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its second quarter results before the market open ...

“Rob and Seth are great additions to the Board of Directors. I look forward to working with them, and John in his new role, to create value for Harvard Bioscience’s shareholders. On behalf of the ...

Reconciling invoices and payments in clinical research has long been a fragmented, time-consuming, and error-prone task. Sites often use multiple siloed systems to manage invoices, while Sponsors and ...

Givastomig is being jointly developed through a global partnership with ABL Bio, in which I-Mab is the lead party and shares worldwide rights equally with ABL Bio, excluding Greater China and South ...

Dogecoin Cash Inc. has established a wholly owned subsidiary, Dogecoin Treasury, Inc. (DTI), which is intended to accumulate DOGE through direct acquisition, mining operations, and other potential ...

The Company intends to use the net proceeds for commercialization efforts, including expanding coverage and improving patient access, global clinical development to advance the core pipeline ...